Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies.


Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 9 6 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: ppublish

Résumé

Specific HBsAg mutations are known to hamper HBsAg recognition by neutralizing antibodies thus challenging HBV-vaccination efficacy. Nevertheless, information on their impact and spreading over time is limited. Here, we characterize the circulation of vaccine-escape mutations from 2005 to 2019 and their correlation with virological parameters in a large cohort of patients infected with HBV genotype-D (

Identifiants

pubmed: 37288750
doi: 10.1080/22221751.2023.2219347
pmc: PMC10251786
doi:

Substances chimiques

Hepatitis B Surface Antigens 0
Hepatitis B Vaccines 0
DNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2219347

Références

J Clin Virol. 2013 Sep;58(1):315-7
pubmed: 23856167
Semin Liver Dis. 2013 May;33(2):103-12
pubmed: 23749666
Hepatol Commun. 2021 Nov;5(11):1807-1809
pubmed: 34719129
World J Hepatol. 2013 Nov 27;5(11):612-20
pubmed: 24303089
Ann Gastroenterol. 2014;27(2):105-112
pubmed: 24733569
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
J Med Virol. 2014 Jan;86(1):97-101
pubmed: 24008988
Vaccines (Basel). 2021 Nov 16;9(11):
pubmed: 34835264
Vaccine. 2021 Jun 29;39(29):3892-3899
pubmed: 34116873
J Clin Virol. 2007 Apr;38(4):353-7
pubmed: 17324621
World J Gastroenterol. 2014 Jun 28;20(24):7653-64
pubmed: 24976703
Lancet Infect Dis. 2021 Sep;21(9):1271-1281
pubmed: 33989539
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
J Hepatol. 2016 Apr;64(1 Suppl):S4-S16
pubmed: 27084035
Emerg Microbes Infect. 2020 Dec;9(1):928-939
pubmed: 32312174
N Engl J Med. 2011 Jan 20;364(3):236-47
pubmed: 21247314
Sci Rep. 2017 Jul 27;7(1):6669
pubmed: 28751727
Viruses. 2020 Feb 23;12(2):
pubmed: 32102257
J Med Virol. 2013 Jun;85(6):996-1004
pubmed: 23588725
J Infect Dis. 2012 Jun;205(11):1757-61
pubmed: 22459735
Nat Commun. 2022 Sep 5;13(1):5207
pubmed: 36064848
Hepatology. 1999 Nov;30(5):1312-7
pubmed: 10534356
J Hepatol. 2017 Feb;66(2):398-411
pubmed: 27575311
Mol Biol Evol. 1987 Jul;4(4):406-25
pubmed: 3447015
Gut. 2019 Feb;68(2):313-321
pubmed: 29959168
N Engl J Med. 2019 May 23;380(21):2041-2050
pubmed: 31116920
JAMA Netw Open. 2021 Oct 1;4(10):e2128652
pubmed: 34636914
Lancet. 1990 Aug 11;336(8711):325-9
pubmed: 1697396
Hepatology. 1998 Jan;27(1):213-22
pubmed: 9425940
J Virol. 1984 Nov;52(2):396-402
pubmed: 6492255
Hepatology. 2022 Jul;76(1):233-250
pubmed: 34990029
Antiviral Res. 2021 Feb;186:104973
pubmed: 33166575
J Infect. 2012 Aug;65(2):180-3
pubmed: 22138369
J Med Virol. 2006;78 Suppl 1:S36-42
pubmed: 16622876
Hepatol Commun. 2021 Nov;5(11):1824-1832
pubmed: 34520121
Mol Biol Evol. 1993 May;10(3):512-26
pubmed: 8336541
J Clin Virol. 2015 Jan;62:89-91
pubmed: 25542480
Hum Vaccin Immunother. 2013 Mar;9(3):568-71
pubmed: 23296324
J Hepatol. 2017 Aug;67(2):370-398
pubmed: 28427875

Auteurs

Lorenzo Piermatteo (L)

Department of Biology, Tor Vergata University, Rome, Italy.
Department of Experimental Medicine, Tor Vergata University, Rome, Italy.

Stefano D'Anna (S)

Department of Experimental Medicine, Tor Vergata University, Rome, Italy.

Ada Bertoli (A)

Department of Experimental Medicine, Tor Vergata University, Rome, Italy.

Maria Bellocchi (M)

Department of Experimental Medicine, Tor Vergata University, Rome, Italy.

Luca Carioti (L)

Department of Experimental Medicine, Tor Vergata University, Rome, Italy.

Lavinia Fabeni (L)

National Institute for Infectious Disease, IRCCS L. Spallanzani, Virology and Biosafety Laboratories Unit, Rome, Italy.

Mohammad Alkhatib (M)

Department of Experimental Medicine, Tor Vergata University, Rome, Italy.

Simone La Frazia (S)

Department of Biology, Tor Vergata University, Rome, Italy.

Miriam Lichtner (M)

Department of Public Health and Infectious Disease, "Sapienza" University, Rome, Italy.

Claudio Mastroianni (C)

Department of Public Health and Infectious Disease, "Sapienza" University, Rome, Italy.

Giuseppe De Sanctis (G)

"Umberto I" University Hospital, Rome, Italy.

Massimo Marignani (M)

Department of Gastroenterology, "S. Andrea Hospital", Rome, Italy.

Caterina Pasquazzi (C)

Department of Gastroenterology, "S. Andrea Hospital", Rome, Italy.

Nerio Iapadre (N)

"San Salvatore Hospital", L'Aquila, Italy.

Giustino Parruti (G)

Infectious Diseases Unit, Pescara General Hospital, Pescara, Italy.

Giuseppina Cappiello (G)

Microbiology and Virology Unit, "S. Pertini" Hospital, Rome, Italy.

Jacopo Vecchiet (J)

Clinic of Infectious Diseases, Department of Medicine and Science of Aging, University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy.

Vincenzo Malagnino (V)

Infectious Diseases Unit, Tor Vergata University Hospital, Rome, Italy.

Sandro Grelli (S)

Department of Experimental Medicine, Tor Vergata University, Rome, Italy.
Virology Unit, Tor Vergata University Hospital, Rome, Italy.

Francesca Ceccherini-Silbertein (F)

Department of Experimental Medicine, Tor Vergata University, Rome, Italy.

Massimo Andreoni (M)

Infectious Diseases Unit, Tor Vergata University Hospital, Rome, Italy.

Loredana Sarmati (L)

Infectious Diseases Unit, Tor Vergata University Hospital, Rome, Italy.

Valentina Svicher (V)

Department of Biology, Tor Vergata University, Rome, Italy.

Romina Salpini (R)

Department of Biology, Tor Vergata University, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH